Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy
Glioma is the most prevalent malignant form of brain tumors, with a dismal prognosis. Currently, cancer immunotherapy has emerged as a revolutionary treatment for patients with advanced highly aggressive thera...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Houshi Xu, Qingwei Zhu, Lan Tang, Junkun Jiang, Huiwen Yuan, Anke Zhang and Meiqing Lou Tags: Primary research Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Immunotherapy | Neurology